Skip to main content
Clinical Trials/NCT03857971
NCT03857971
Active, Not Recruiting
N/A

Identification of Risk Factors for Acute Coronary Events by Optical Coherence Tomography After STEMI and NSTEMI in Patients With Residual Non-flow Limiting Lesions The 'PECTUS-obs' Trial (Observational Cohort)

Radboud University Medical Center1 site in 1 country438 target enrollmentDecember 14, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Myocardial Infarction
Sponsor
Radboud University Medical Center
Enrollment
438
Locations
1
Primary Endpoint
Major Adverse Cardiac Events
Status
Active, Not Recruiting
Last Updated
4 years ago

Overview

Brief Summary

The objective of this study is to compare the clinical outcome of Non-ST-elevation myocardial infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI) patients with non-obstructive, non-culprit coronary lesions and either presence or absence of vulnerable plaque characteristics as assessed by optical coherence tomography (OCT).

Detailed Description

Despite major advances in the treatment of acute coronary syndromes a large proportion of patients is still at risk for new coronary events after experiencing an acute coronary syndrome (ACS). Detection of residual vulnerable plaques after ACS using OCT potentially identifies patients at high risk for new coronary events. However, no prospectively collected data on the prognostic power of OCT for plaque rupture are available at this moment. To design trials aimed to reduce events in patients with vulnerable plaques it is required to collect such prospective data on the relation between OCT derived characteristics of vulnerability and clinical outcome.

Registry
clinicaltrials.gov
Start Date
December 14, 2018
End Date
June 14, 2025
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Informed consent must be obtained.
  • Patients with STEMI or NSTEMI and residual, non-culprit CAD, with the possibility of plaque vulnerability.
  • Residual plaque(s) is(are) non-obstructive (FFR≥0.80).

Exclusion Criteria

  • Refusal or inability to provide informed consent.
  • \< 18 years of age
  • Hemodynamic instability, respiratory failure, Kilip class ≥
  • Previous Coronary Artery Bypass Grafting (CABG).
  • Indication for revascularization by CABG.
  • Anatomy or lesions unsuitable for OCT catheter crossing or imaging (aorta-ostial lesions, small diameter segment, severe calcifications, lesion is too distal for OCT catheter)
  • Pregnancy.
  • Estimated life expectancy \< 3 year

Outcomes

Primary Outcomes

Major Adverse Cardiac Events

Time Frame: 2 years

Composite of all cause mortality, non-fatal myocardial infarction or unplanned revascularization.

Secondary Outcomes

  • Target lesion Failure(2 and 5 years)
  • Major Adverse Cardiac Events(5 years)

Study Sites (1)

Loading locations...

Similar Trials